Published date: 24 September 2018

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Closing: 25 October 2018

Contract summary

Industry

  • Health services - 85100000

Location of contract

London

Value of contract

£0

Procurement reference

tender_188477/714116

Published date

24 September 2018

Closing date

25 October 2018

Contract start date

1 April 2019

Contract end date

31 March 2021

Contract type

Service contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

The British Bone Marrow Registry (BBMR) is a division of NHS Blood and Transplant. The Northern Ireland and Scottish Blood Transfusion Services are participants in the service provided by the BBMR.

The BBMR supports HSC Clinical Transplantation Programmes for UK and International patients. It recruits prospective stem cell donors from the blood donor population. The donors are tissue typed and they are then available to be searched by accredited Transplant Centres or laboratories acting on their behalf for patients with leukaemia and other blood disorders. After further identification testing a donor may be selected as the final donor. The BBMR collects HSC products from donors between the ages of 18 and 60.

The finally selected donor is counselled and informed consent for the donation obtained. Donor counselling is currently performed by the BBMR in accordance with Human Tissue Authority (HTA) and World Marrow Donor Association (WMDA) requirements. Responsibility for this service can be undertaken by the service provider.

The donor must be medically assessed and fitness to donate the HSC product determined. The medical assessment of the donor includes the risk of disease transmission to the recipient.

The source of stem cells for First and Subsequent donations is from the Bone Marrow under General Anaesthetic (GA) as an inpatient, or Peripheral Blood stimulated by Granulocyte Colony Stimulating Factor (G-CSF) as an outpatient procedure. Subsequent donations for the same patient may also include blood lymphocytes.

For a peripheral blood stem cell collection donors receive a short course of G-CSF, 4 or 5 days. The successful bid service provider will prescribe G-CSF as Lenograstim, Granocyte®.

BBMR require a Collection Centre, located in the Central London area

The service provider will procure, label and issue the HSC product, for distribution under direction from BBMR.
.

More information

Links

Additional text

NHSBT will be running a tender through Bravo Solutions ePortal, please follow the instructions below to register on the system. This will be published on 25th September 2018 and will close on 25th October 2018.

To register your company on the eSourcing portal (this is only required once) - Browse to the eSourcing Portal at https://nhsbt.bravosolution.co.uk - Click the "Register now!" link - Accept the terms and conditions and click "continue" - Enter your correct business and user details - Note the username you chose and click "Save" when complete - You will shortly receive an email with your unique password (please keep this secure).

About the buyer

Contact name

Janice Allen

Address

500 Northway
Filton
BS34 7QH
England

Email

janice.allen@nhsbt.nhs.uk